AbCellera Biologics Inc.

ABCL
As of the close on Sep 25, 2026
Price
$12.70
Market cap
$3.89B
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$0.54
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How AbCellera Biologics Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: AbCellera Biologics Inc. — 10-Q filed Aug 5, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
AMERICAN CENTURY COMPANIES INC 2026-03-31 109,011 $380K SEC filing
Jump Financial, LLC 2026-03-31 98,600 $344K SEC filing
Virtus Investment Advisers, LLC 2026-03-31 75,327 $263K SEC filing
Quantbot Technologies LP 2026-03-31 34,536 $121K SEC filing
XML Financial, LLC 2026-03-31 42,025 $147K SEC filing
Alyeska Investment Group, L.P. 2026-03-31 2,592,105 $9.05M SEC filing
Blume Capital Management, Inc. 2026-03-31 2,800 $9.77K SEC filing
&PARTNERS 2026-03-31 10,000 $34.9K SEC filing
Intesa Sanpaolo S.p.A. 2026-03-31 164,371 $567K SEC filing
Capital World Investors 2026-03-31 13,361,096 $46.6M SEC filing
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2026-03-31 7,575,476 $26.4M SEC filing
RENAISSANCE TECHNOLOGIES LLC 2026-03-31 1,510,629 $5.27M SEC filing
HighTower Advisors, LLC 2026-03-31 95,933 $335K SEC filing
CIBC WORLD MARKET INC. 2026-03-31 17,796 $62.1K SEC filing
Guardian Partners Inc. 2026-03-31 1,786,415 $6.25M SEC filing
Handelsbanken Fonder AB 2026-03-31 115,700 Not shown SEC filing
Janney Montgomery Scott LLC 2026-03-31 13,043 Not shown SEC filing
HSBC HOLDINGS PLC 2026-03-31 143,472 $499K SEC filing
Integrity Financial Corp /WA 2026-03-31 10,000 $34.9K SEC filing
Cornerstone Planning Group LLC 2026-03-31 2,000 Not shown SEC filing
  • Each value is checked against AbCellera Biologics Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at AbCellera Biologics Inc.'s share price.
  • Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.

120 filers have only one report here.

Independent insiders buying near the same time

  • 2026-02-26–2026-02-27: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
  • 2025-03-06–2025-03-11: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
  • 2023-05-26–2023-05-26: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
  • 2022-05-12–2022-05-16: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
  • 2022-02-28–2022-03-04: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
  • 2021-11-11–2021-11-11: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-05-14Montalbano John S. · DirectorCommon SharesP — Open market or private purchase+20,0004.77SEC filing
2026-02-27Thermopylae Holdings Ltd. · 10% ownerCommon SharesP — Open market or private purchase+38,0003.44SEC filing
2026-02-27Booth Andrew · Chief Financial OfficerCommon SharesP — Open market or private purchase+42,6003.42SEC filing
2026-02-26Thermopylae Holdings Ltd. · 10% ownerCommon SharesP — Open market or private purchase+177,4573.27SEC filing
2025-11-26Montalbano John S. · DirectorCommon SharesP — Open market or private purchase+50,0003.57SEC filing
2025-03-11Thermopylae Holdings Ltd. · 10% ownerCommon SharesP — Open market or private purchase+343,6312.16SEC filing
2025-03-10Montalbano John S. · DirectorCommon SharesP — Open market or private purchase+25,0002.30SEC filing
2025-03-06Montalbano John S. · DirectorCommon SharesP — Open market or private purchase+60,0002.34SEC filing

Showing 8 of 20 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-11Hayden Michael R · DirectorShare option (right to buy)A — Grant, award, or other acquisition+111,701SEC filing
2026-06-11Quake Stephen · DirectorShare option (right to buy)A — Grant, award, or other acquisition+111,701SEC filing
2026-06-11Montalbano John S. · DirectorShare option (right to buy)A — Grant, award, or other acquisition+111,701SEC filing
2026-06-03Booth Andrew · Chief Financial OfficerShare option (right to buy)M — Exercise or conversion of derivative security−250,000SEC filing
2026-06-03Booth Andrew · Chief Financial OfficerCommon SharesM — Exercise or conversion of derivative security+250,000SEC filing
2026-01-01Stimart Tryn · Chief Legal OfficerShare option (right to buy)A — Grant, award, or other acquisition+539,265SEC filing
2026-01-01Hansen Carl L. G. · Chief Executive OfficerShare option (right to buy)A — Grant, award, or other acquisition+2,106,505SEC filing
2026-01-01Booth Andrew · Chief Financial OfficerShare option (right to buy)A — Grant, award, or other acquisition+808,898SEC filing

Showing 8 of 30 rows

Other activity

SecurityCodeFiling
2021-06-18DCVC Bio, L.P. · 10% ownerCommon SharesJ — Other acquisition or disposition−5,000,000SEC filing
2021-06-18DCVC Bio, L.P. · 10% ownerCommon SharesJ — Other acquisition or disposition+73,892SEC filing
2021-06-18HAMER JOHN · Director, 10% ownerCommon SharesJ — Other acquisition or disposition−5,000,000SEC filing
2021-06-18HAMER JOHN · Director, 10% ownerCommon SharesJ — Other acquisition or disposition+73,892SEC filing

Showing 4 of 4 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.